Worcester, MA, United States of America

Michelle L R Heffernan

This inventor holds 2 USPTO granted patents. Top assignee: Sepracor, Inc.. Active years: 2004-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michelle L R Heffernan. Retrieved from https://idiyas.com/inventor/michelle-l-r-heffernan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michelle L R Heffernan: Innovator in Stereoselective Synthesis

Introduction

Michelle L R Heffernan is a notable inventor based in Worcester, MA (US). She has made significant contributions to the field of chemistry, particularly in the synthesis of substituted piperidines. With a total of 2 patents, her work is aimed at addressing various medical conditions.

Latest Patents

Heffernan's latest patents focus on methods for the stereoselective synthesis of substituted piperidines. One aspect of her invention relates to synthesizing these compounds, which are useful for treating numerous ailments, including addiction and pain. Additionally, her methods facilitate the creation of combinatorial libraries of substituted piperidines. The invention also encompasses enantiomerically substituted pyrrolidines, piperidines, and azepines.

Career Highlights

Heffernan is currently employed at Sepracor, Inc., where she continues to innovate in her field. Her work has the potential to impact the pharmaceutical industry significantly, providing new avenues for treatment.

Collaborations

Some of her notable coworkers include Brian M Aquila and Thomas D Bannister, who contribute to her research endeavors.

Conclusion

Michelle L R Heffernan is a pioneering inventor whose work in stereoselective synthesis is paving the way for advancements in medical treatments. Her contributions are vital to the ongoing development of effective therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…